The phase 3 DELTA TEEN trial evaluating Anzupgo 20 mg/g cream for the treatment of chronic hand eczema in adolescents has shown positive results, LEO Pharma announced in a press release. The 16-week, ...
Investor's Business Daily on MSN6h
Arcutis Soared In 2024, Blazing Trails In Dermatology. Why Its CEO Eyes Bigger Gains.Arcutis Biotherapeutics has a lofty goal for 2025 — and it could help Arcutis stock continue a massive run that helped shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback